| Document |
Document Title |
|
JP5118626B2 |
Ethanol was produced using biocatalysts that are able to ferment sugars derived from treated biomass. Sugars were obtained by pretreating biomass under conditions of high solids and low ammonia concentration, followed by saccharification.
|
|
JP5121187B2 |
|
|
JP2013006142A |
To provide a long-life catalyst which improves the reaction rate, has high activity under the condition of not high reaction temperature (a temperature condition near a room temperature), and can endure repeated use, upon hydrolyzing a p...
|
|
JP5116071B2 |
PROBLEMS To control neuropathic pain produced by various mechanisms. [MEANS FOR SOLVING PROBLEMS] Disclosed is a composition for elimination, relief or reduction of neuropathic pain comprising, as an active ingredient, at least one subst...
|
|
JP5116072B2 |
[PROBLEMS] To provide a composition having an effect of preventing the rapid increase in blood glucose level upon the intake of a carbohydrate and/or a sugar. [MEANS FOR SOLVING PROBLEMS] Disclosed is a composition comprising D-allose wh...
|
|
JP2012254061A |
To provide an enzyme having nigerose phosphorolytic activity.The invention relates to the enzyme having activity for producing glucose and β-glucose 1 phosphoric acid by specific and reversible phosphorolysis of the nigerose.
|
|
JP5106097B2 |
The invention provides a process for preparing heparin products with a reduced content of glycoserine. A method for detecting glycoserine in preparations of heparin is also provided.
|
|
JP5103597B2 |
Object: To provide a thermostable L-ribose isomerase. Means for ReThe thermostable L-ribose isomerase with MW. 32,000 (by SDS-PAGE), optimal temperature of 45°C, optimal pH of pH 9. 0 (glycine-NaOH buffer), and stable physicochemical pr...
|
|
JP2012532195A |
The invention relates to a method of inhibiting inflammation with milk oligosaccharides or glycoconjugates containing the oligosaccharides.
|
|
JP5093472B2 |
|
|
JP5085136B2 |
The present invention relates to the use of known and novel compounds as inhibitors of UDP-GlcNAc:Galβ1,3GalNAc-R (GlcNAc to GalNAc) β1,6-N-acetylglucosaminyl transferase (core 2 β1,6 N-acetylaminotransferase, core 2 GlcNAc-T-EC 2.4.1...
|
|
JP5082570B2 |
|
|
JP5079331B2 |
Medicament comprises a reducing sugar derivative (I) in which a hydroxy group is replaced by an alkoxy group with 2-40 carbon atoms. Independent claims are also included for: (1) cosmetic treatment of skin and/or mucosa that are sensitiv...
|
|
JP5058420B2 |
Production of an oligosaccharide (I) from an exogenous precursor (II) comprises obtaining a cell which expresses at least one gene coding for an enzyme involved in the conversion of (II) to (I) and lacks enzyme activity capable of degrad...
|
|
JP2012523952A |
A new and effective method for supporting and/or intensifying a physical and/or chemical reaction in a reaction volume of a reactor (13), which is filled with a plurality of substances, comprises the steps of: providing a reactor (13) ha...
|
|
JP5047489B2 |
Use of powdery anhydrous dextrose composition (A) (comprising: particles (4 vol.%) with size of 40 micron and particles (8 vol.%) with size of 100 micron; hygroscopic index less than 1% and density higher than 0.7 kg/l), as non-food and ...
|
|
JP5044717B1 |
To provide an oligosaccharide having a novel structure and a production method. β-D-fructofuranosyl- (2 1) -β-D-glucopyranoside represented by the formula (1). [Selection diagram] None
|
|
JP2012188426A |
To provide a lipid metabolism-improving composition expectable of preventive effect and improving effect of hyperlipidemia, obesity, etc., by improving the metabolism of the lipid.The lipid metabolism-improving composition contains difru...
|
|
JP5038687B2 |
|
|
JP2012184190A |
To provide 4-keto-D-ribonic acid which is a novel compound, a method for producing the 4-keto-D-ribonic acid, 4-keto-D-ribose and a method for producing the 4-keto-D-ribose.A 4-keto-D-ribonic acid producing microorganism and a 4-keto-D-r...
|
|
JP2012522827A |
The present invention relates to an improved synthesis of a trisaccharide of the formula (1), novel intermediates used in the synthesis and the preparation of the intermediates.
|
|
JP5030045B2 |
|
|
JP5027395B2 |
|
|
JP2012176907A |
To provide a novel myosin light chain dephosphorylation promoter, a preventive or therapeutic agent for diseases caused by the phosphorylation of a myosin light chain, and food and drink containing the promoter.The myosin light chain dep...
|
|
JP2012167118A |
To provide a high throughput, high purity, high yield system and method of isolating and purifying rebaudioside A ("Reb A"), with acceptable water solubility for all commercial uses, from commercially available Stevia rebaudiana starting...
|
|
JP5020769B2 |
|
|
JP5021223B2 |
|
|
JP5011108B2 |
A process for preparing an oligosaccharide derivative from an oligosaccharide mixture, the process being characterized in that the process comprises the steps of (a) introducing a lipophilic group into oligosaccharides of the mixture to ...
|
|
JP5011489B2 |
The object of the present invention is to provide a composition of metal ion compound whose inherent and unsatisfactory properties for its industrial application such as deliquescence, reducing power, oxidizing power, low solubility in w...
|
|
JP2012158526A |
To provide a method for efficiently producing α-bonded mannooligosaccharide with an economical method by using D-mannose as the raw material.There is provided a method for preferentially producing α-bonded mannooligosaccharide which me...
|
|
JP5008910B2 |
|
|
JP5007417B2 |
The present invention is to provide means of inhibiting chemical changes in unsaturated compounds by radical reactions through inhibition of radical formation in such an unsaturated compound: The present invention attains such an objecti...
|
|
JP5004950B2 |
The present invention provides processes for the production of polysaccharides containing the L-iduronate subunit, for example, heparin-type polysaccharides. New intermediate compounds and processes developed during the production of sai...
|
|
JP5007878B2 |
The invention relates to a process of recovering galactose from a solution derived from plant-based biomass. In the process of the invention, the starting solution is subjected to one or more chromatographic fractionation steps, which ma...
|
|
JP5000874B2 |
The invention provides a sucrase activity inhibitor and a glucoamylase activity inhibitor comprising one or more saccharides selected from the group consisting of palatinose, trehalulose and palatinit. Further, the invention provides a f...
|
|
JP4984203B2 |
The present invention is directed to a method comprising a multistep process for recovering one or more monosaccharides from a solution containing at least two monosaccharides selected from the group consisting of rhamnose, arabinose, xy...
|
|
JP4982643B2 |
|
|
JP4982649B2 |
To provide a method for enhancing life activity and/or expanding suitable region for the life activity of a living body such as an animal or a plant in an aqueous solution which is the environment of the living body. The method for enhan...
|
|
JP4983258B2 |
The present invention have objects to provide an option of non-reducing saccharide by providing a novel non-reducing saccharide composed of glucose as constituents and to provide a novel enzyme forming the non-reducing saccharide, a meth...
|
|
JP4982716B2 |
|
|
JP4980667B2 |
|
|
JP4973970B2 |
The invention relates to a method comprising a multistep process for recovering betaine, erythritol, inositol, sucrose, mannitol, glycerol and amino acids from corresponding starting materials. The invention comprises the use of a weakly...
|
|
JP4966429B1 |
An object of the present invention is to provide a method for producing a saccharide polycondensate which is inexpensive and is applicable to a food or beverage product. Disclosed is a method for producing a saccharide polycondensate, wh...
|
|
JP2012121823A |
To provide an insulin secretagogue which is effective in preventing diabetes and the like and which is highly safe and free of concern of side effects even when ingested continuously.This insulin secretagogue contains, as an active ingre...
|
|
JP4960591B2 |
|
|
JP2012111758A |
To provide a compound to be used in the method for detecting glycoserine in preparations of heparin in the method for preparing a heparin product having a reduced content of glycoserine.The compound is represented by formula (A).
|
|
JP4950436B2 |
|
|
JP2012512865A |
The present invention relates to a process for the synthesis of L-fucosyl di- or oligosaccharides and their novel 2,3,4-tri-O-benzyl-fucosyl synthetic intermediates derivatives of easy crystallization. In particular the present invention...
|
|
JP2012107044A |
To provide a trehalose-releasing enzyme for producing trehalose from reducible starch partially decomposed subject and a method for producing the same and to establish the uses thereof.A novel trehalose-releasing enzyme, the method for p...
|
|
JP4945710B2 |
Ribose administered before exercise reduces or prevents exercise-induced muscle cramping and soreness. Ribose taken both before and immediately after exercise further reduces or prevents exercise-induced muscle cramping and soreness.
|
